University of Florida

2004 Mowry Road CTRB
Gainesville, FL 32610
United States
Call 877-343-2377 Email this location

The University of Florida (UF) is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Desmond Schatz, MD, the TrialNet team at UF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Our Team

Principal Investigators 
Desmond
Schatz
MD
Michael
Haller
MD
Mark
Atkinson
PhD
Laura
Jacobson
MD
Research Coordinators 
Annie
Abraham
Jennifer
Hosford
MPH
Madison
Smith
RN, BSN
PD
Towe
"Our mission is to improve the lives of patients and families affected by type 1 diabetes. Until there is an effective means of preventing and reversing type 1 diabetes, we will continue to work towards making that dream a reality"-Michael Haller, MD, University of Florida

Regional Affiliates

Affiliates provide opportunities for people who do not live near a TrialNet Clinical Center. The affiliate sites listed below work with UF to offer convenient participation in our research programs
Atlanta

Augusta University Satellite Clinic
6105 Peachtree Dunwoody Rd, Atlanta, GA 30328

Augusta

Augusta University
1120 15th St., Augusta, GA 30912

Charleston

Medical University of South Carolina
96 Jonathan Lucas St, Charleston, SC 29425

Columbia

University of South Carolina, School of Medicine
9 Medical Park Drive Suite 230A, Columbia, SC 29203

Greenville

GHS - Pediatric Endocrinology
200 Patewood Drive, Suite A320, Greenville, SC 29615

Greenville

Endocrinology Specialists
877 West Faris Road, Greenville, SC 29605

Jacksonville

Nemours Childrens Clinic-Jacksonville
807 Children's Way, Jacksonville, FL 32207

Knoxville

East Tennessee Childrens Hospital
2100 Clinch Avenue, Children's Hospital Medical Office Building, Knoxville, TN 37916

Orlando

Nemours Childrens Clinic-Orlando
6900 Lake Nona Blvd, Orlando, FL 32827

Orlando

Arnold Palmer Pediatric Endo
89 W. Copeland Drive, 2nd Floor, Orlando, FL 32806

Orlando

Translational Research Institute for Metabolism and Diabetes
601 E. Rollins, Box 207, Orlando, FL 32803

Pensacola

Nemours Children's Clinic-Pensacola
5153 N 9th Ave, Pensacola, FL 32504

Port Charlotte

Hanson Clinical Research Center
21216 Olean Blvd. Suite 8, Port Charlotte, FL 33952

Raleigh

WakeMed Children's Diabetes and Endocrinology
23 Sunnybrook Rd,, Raleigh, NC 27511

Tallahassee

Larry C. Deeb MD
2804 Remington Green Circle, Suite 1, Tallahassee, FL 32308

"Screening is the first step on the pathway to prevention. Those who test positive for an increased risk may be able to join other research studies testing ways to delay and prevent the disease. Without prevention, there can be no cure" Desmond Schatz, MD, University of Florida

Research Studies

Risk Screening

Pathway to Prevention

If you have a relative with T1D, you’re in a unique position to help us learn more about the disease and how to stop it. The first step is to sign up for Pathway to Prevention screening to determine your risk of developing T1D.

More

Prevention Study

Abatacept

TrialNet is testing the drug abatacept to see if it can delay or prevent progression of early stage T1D (stage 1 to stage 2) and ultimately prevent clinical diagnosis (stage 3). In earlier studies for people newly diagnosed (stage 3), abatacept helped slow down disease progression.

More

Teplizumab (Closed to Enrollment-Study Ongoing)

We are testing the drug teplizumab to see if it can delay or prevent progression of early stage T1D (stage 2) and prevent clinical diagnosis (stage 3). In earlier studies in people newly diagnosed (stage 3), teplizumab helped to prolong insulin production.

More

Hydroxychloroquine (HCQ)

We are testing the drug hydroxychloroquine (HCQ) to see if it can delay or prevent early stage T1D (stage 1) from progressing to abnormal glucose tolerance (stage 2) and ultimately prevent clinical diagnosis (stage 3). HCQ is already used to reduce symptoms and progression of other autoimmune diseases, such as rheumatoid arthritis and lupus. This is the first study to see if it can prevent or delay T1D.

More

Longterm

Long-Term Investigative Follow-Up in TrialNet (LIFT)

Once your study ends, we're still here for you. Participant monitoring and continued involvement helps us learn more about T1D.

More